Registry following people with structural ventricular arrhythmias in China
Observes people with heart rhythm disorders to build a risk assessment tool.
Plain-language title generated from the registry record
Registry title: China Structural Ventricular Arrhythmias Registry
Key facts
- Where
- Beijing, ChinaSee the site
AI summary: who the study is looking for
From the trial's eligibility criteria. Machine-read from the registry text on this page, so it can be wrong. The registry text below and the trial team decide who can take part.
The registry is looking for people with ventricular arrhythmia (a dangerous heart rhythm problem) caused by structural heart disease.
- Sex
- Women and men can join.
- Disease stage
- Ventricular arrhythmia caused by structural heart disease, such as ischemic cardiomyopathy, arrhythmogenic right ventricular cardiomyopathy, dilated cardiomyopathy or hypertrophic cardiomyopathy.
Read by machine on 12 November 2026.
Where in China
- China National Center for Cardiovascular DiseasesBeijing, ChinaContact: Yan Yao, MD, PhDTaking people
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Contact the study team: see the registry record → Contacts and Locations
Print a page for my doctorTrial details
- Who runs it
- China National Center for Cardiovascular Diseases
- Trial code
- NCT03821051
- Record updated
- 29 January 2019
- Original description
This is an observational, prospective, multi-center registry ,aiming at building a risk stratification for malignant structural ventricular arrhythmias. 2000 participants will be recruited from 10 centers in China,with clinical data to be abstracted from medical records ,and blood samples to be collected for finding promising risk indicators.The follow-up should be made every 6 mouths.Read full original descriptionShow less
China Structural Ventricular Arrhythmias Registry, a Multicenter，Observational and Prospective Study.
This is an observational, prospective, multi-center registry ,aiming at building a risk stratification for malignant structural ventricular arrhythmias. 2000 participants will be recruited from 10 centers in China,with clinical data to be abstracted from medical records ,and blood samples to be collected for finding promising risk indicators.The follow-up should be made every 6 mouths.
Inclusion: diagnosed as ventricular arrhythmia resulted by structural heart diseases, including ischemic cardiomyopathy, arrhythmogenic right ventricular cardiomyopathy, dilated cardiomyopathy, hypertrophic cardiomyopathy, etc.
Exclusion: none.